APOB and coronary artery disorder: Non-HDL-C is a more comprehensive measure of atherogenic particles than LDL-C and is superior to LDL-C in its ability to predict MACE, thus, non-HDL-C has been shown to predict CHD similarly to apolipoprotein B. We suggest that in clinical practice, more attention should be directed to non-HDL-C and to achieving non-HDL-C goals in patients at increased cardiovascular risks.